Holen Sie sich die Stockscreener-App
11.42
1.33%
0.15
Handel nachbörslich:
11.42
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt NEO?
Forum
Prognose
Aktiensplit
Neogenomics Inc Aktie (NEO) Neueste Nachrichten
Trading Systems Reacting to (NEO) Volatility - Stock Traders Daily
Update Recap: Is Capital One Capital II LLC Preferred Security stock a top performer YTDJuly 2025 Reactions & Smart Allocation Stock Tips - baoquankhu1.vn
165,890 Shares in NeoGenomics, Inc. $NEO Purchased by Y Intercept Hong Kong Ltd - MarketBeat
Aug Movers: Can LCFYW sustain its profitability2025 Retail Activity & Growth Oriented Trading Recommendations - baoquankhu1.vn
NeoGenomics, Inc. (NASDAQ:NEO) Given Average Recommendation of "Hold" by Analysts - MarketBeat
US Stocks Recap: Can NeoGenomics Inc deliver alphaJuly 2025 Pullbacks & Reliable Price Breakout Alerts - baoquankhu1.vn
NeoGenomics to Report Fourth Quarter and Full Year 2025 Financial Results on February 17, 2026 - BioSpace
Press Release: NeoGenomics to Report Fourth Quarter and Full Year 2025 Financial Results on February 17, 2026 - 富途牛牛
NeoGenomics: Distribution Moat In Community Oncology (NASDAQ:NEO) - Seeking Alpha
Should NeoGenomics’ CFO Transition and Early 2025 Revenue Signals Require Action From NEO Investors? - simplywall.st
Published on: 2026-01-25 10:30:50 - baoquankhu1.vn
Don't Ignore The Insider Selling In NeoGenomics - Sahm
Neogenomics pres. Stone sells $277k in NEO stock By Investing.com - Investing.com India
NeoGenomics (NASDAQ:NEO) COO Sells 22,128 Shares of Stock - MarketBeat
Neogenomics pres. Stone sells $277k in NEO stock - Investing.com
Anatomic Pathology Market Innovations and Key Players: Agilent - openPR.com
Volume Report: Why is NeoGenomics Inc stock going upEarnings Growth Summary & Smart Money Movement Tracker - baoquankhu1.vn
NeoGenomics, Inc. (NEO) Stock Analysis: Unpacking a 12.81% Upside Potential Amidst Healthcare Diagnostics Growth - DirectorsTalk Interviews
Is NeoGenomics Inc. stock overvalued or fairly pricedFinancial Sector Performance & Target Triple-Digit Stock Opportunities - bollywoodhelpline.com
Aug Sentiment: Why is NeoGenomics Inc stock going upRate Cut & AI Enhanced Market Trend Forecasts - baoquankhu1.vn
How NeoGenomics’ (NEO) CFO Transition and Double‑Digit Revenue Guidance Has Changed Its Investment Story - simplywall.st
Pullback Watch: Should you buy the dip on NeoGenomics IncJuly 2025 Trade Ideas & Smart Swing Trading Alerts - baoquankhu1.vn
NeoGenomics (NASDAQ:NEO) Raised to Strong-Buy at Zacks Research - MarketBeat
What’s the analyst consensus on NeoGenomics Inc.2025 Pullback Review & Weekly Sector Rotation Insights - bollywoodhelpline.com
Analysts Offer Insights on Healthcare Companies: Crispr Therapeutics AG (CRSP) and NeoGenomics (NEO) - The Globe and Mail
Aug Volume: Is NeoGenomics Inc stock undervalued right nowQuarterly Profit Summary & Fast Gain Stock Trading Tips - baoquankhu1.vn
NeoGenomics names incoming CFO amid revenue growth - Gulfshore Business
NeoGenomics, Inc. (NEO) Stock Analysis: Assessing A 16.59% Potential Upside - DirectorsTalk Interviews
NeoGenomics forecasts 11% revenue growth for Q4 2025, names new CFO - Investing.com Nigeria
NeoGenomics (NASDAQ:NEO) Shares Down 7.4%Here's What Happened - MarketBeat
NeoGenomics, Inc. Announces Chief Financial Officer Changes - marketscreener.com
NeoGenomics, Inc. Announces Executive Changes - marketscreener.com
Fort Myers-based NeoGenomics expects big revenue increase for 2025 - news-press.com
NeoGenomics (NASDAQ:NEO) Earns "Buy" Rating from Needham & Company LLC - MarketBeat
NeoGenomics Appoints Diagnostics and Lab Services Industry Veteran John P. “Jack” Kenny to its Board of Directors - The National Law Review
NeoGenomics Announces Preliminary Fourth Quarter and Full-Year 2025 Revenue - PharmiWeb.com
NeoGenomics sees Q4 revenue of about $190M - MSN
NeoGenomics prelim Q4 revenue slightly beats estimates, names insider as CFO - TradingView
NeoGenomics announces board changes to support future growth - MSN
How NeoGenomics Inc. stock reacts to oil prices2025 Biggest Moves & Weekly Return Optimization Plans - Улправда
Will NeoGenomics Inc. stock attract more institutional investorsMarket Risk Analysis & Daily Risk Controlled Trade Plans - Улправда
Will NeoGenomics Inc. stock benefit from infrastructure spending2025 Macro Impact & Fast Moving Trade Plans - Улправда
Neogenomics Shares Surge on Strategic and Legal Developments - AD HOC NEWS
Will NeoGenomics Inc. stock outperform international peersQuarterly Market Summary & Smart Money Movement Alerts - Улправда
A Look At NeoGenomics (NEO) Valuation After Recent Share Price Momentum Shift - Yahoo Finance
NeoGenomics, Inc. (NEO) Investor Outlook: Diagnostic Leader With 18% Upside Potential - DirectorsTalk Interviews
NeoGenomics to Present at 44th Annual J.P. Morgan Healthcare Conference - Intellectia AI
NeoGenomics to Participate in the 44th Annual J.P. Morgan Healthcare Conference - The AI Journal
NeoGenomics, Inc. (NASDAQ:NEO) Given Consensus Rating of "Hold" by Analysts - MarketBeat
NeoGenomics Adds Diagnostics Executive Jack Kenny To Board - Pulse 2.0
0.83%
1.17%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):